OR6C6 Inhibitors
Chemical inhibitors of OR6C6 function by interacting with various aspects of the protein's environment or structure to inhibit its olfactory signaling capabilities. Zinc acetate and Copper(II) sulfate achieve inhibition by directly binding to OR6C6. This binding can either occur at the protein's active site or lead to a change in the protein's conformation, which prevents OR6C6 from interacting with odorant molecules, thus obstructing olfactory signal transduction. Chloroquine exerts its effect by integrating into the lipid bilayer of olfactory neurons, potentially modifying the membrane environment and receptor conformation, resulting in inhibited function of OR6C6. Similarly, Lidocaine's mechanism of inhibition is through stabilizing the inactive form of neuronal ion channels, which indirectly affects OR6C6 by altering the neuronal membrane potential that is essential for the protein's activation and signal relay.
Further interacting with the olfactory neuron's signaling, Tetraethylammonium and Quinine act as blockers of potassium and other ion channels, respectively. Tetraethylammonium's blockade of potassium channels can modify neuronal excitability, which indirectly affects OR6C6 by altering the electrical signaling necessary for its activation. Quinine's role as an ion channel blocker can also inhibit the function of channels involved in olfactory signaling, altering the ionic currents that facilitate OR6C6 signaling. Ruthenium red, Verapamil, Diltiazem, and Nifedipine inhibit different types of calcium channels, which are vital for calcium-dependent signaling pathways. These pathways are crucial for OR6C6 activity, as calcium influx is necessary for olfactory signal transduction. The inhibition of these channels reduces calcium signaling, which in turn decreases the activity of OR6C6. Lastly, Amiloride and Methylene blue target other aspects of cellular signaling; Amiloride by inhibiting sodium channels and thereby affecting the membrane potential, and Methylene blue by inhibiting guanylyl cyclase, reducing levels of cGMP and subsequently impairing cGMP-dependent pathways necessary for OR6C6's functional role in olfactory perception.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc acetate can functionally inhibit OR6C6 by binding to the protein's active site or altering its conformation. This binding can prevent OR6C6 from interacting with its specific odorant molecules, leading to a decrease in olfactory signal transduction. | ||||||
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $46.00 $122.00 $189.00 | 3 | |
Copper(II) sulfate can bind with OR6C6, potentially causing conformational changes that inhibit the protein's ability to bind to its ligands, thus inhibiting OR6C6's role in olfactory perception. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can insert into the lipid bilayer of olfactory neurons and may alter the membrane environment and receptor conformation, leading to inhibition of OR6C6 by preventing its proper functioning in the olfactory signaling pathway. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Lidocaine can stabilize the inactive form of neuronal ion channels, which can indirectly inhibit OR6C6 by disrupting the neuronal membrane potential essential for OR6C6 activation and subsequent signal transduction. | ||||||
Quinine | 130-95-0 | sc-212616 sc-212616A sc-212616B sc-212616C sc-212616D | 1 g 5 g 10 g 25 g 50 g | $79.00 $104.00 $166.00 $354.00 $572.00 | 1 | |
Quinine, as an ion channel blocker, can inhibit the function of ion channels involved in olfactory signal transduction, which can indirectly inhibit OR6C6 by altering the ionic currents that facilitate its signaling. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Ruthenium red functions as a calcium channel blocker, which can inhibit calcium-dependent signaling pathways. This inhibition can decrease the activity of OR6C6, as calcium influx is crucial for olfactory signal transduction involving this protein. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil inhibits voltage-gated calcium channels, leading to reduced calcium signaling in neurons. This can inhibit OR6C6 activity by preventing the calcium-mediated signaling required for its function in the olfactory system. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem inhibits calcium channels, leading to a decrease in intracellular calcium levels. This reduction can inhibit OR6C6 by limiting calcium-dependent processes that are necessary for the functional activation of this olfactory receptor in response to odorants. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine inhibits L-type calcium channels, which can reduce calcium influx. This inhibition can decrease the activity of OR6C6 by interrupting the calcium-dependent signaling mechanisms required for the protein's role in olfactory transduction. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride inhibits epithelial sodium channels and can disrupt sodium homeostasis. This disruption can indirectly inhibit OR6C6 by affecting the membrane potential and ionic balance critical for the receptor's activation and signal propagation in olfactory neurons. | ||||||